Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Metarmor

2015 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$359K LATEST DEAL AMOUNT
Description

Developer of drug for prevention of hearing loss. The company specializes in developing and commercializing a drug that protects hair cells in the inner ear for prevention of hearing loss and auditory damage.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 307 North Polktown Road
  • Glen Gardner, NJ 08826
  • United States

+1 (908) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Metarmor’s full profile, request a free trial.

Metarmor Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 09-Jun-2017 $359K 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Metarmor Executive Team (1)

Name Title Board
Seat
Contact
Info
Jennifer Seibert Chief Executive Officer & Board Member

Metarmor Board Members (4)

Name Representing Role Since Contact
Info
Frances Engoron Metarmor Board Member 000 0000
Jennifer Seibert Metarmor Chief Executive Officer & Board Member 000 0000
Joseph Walker Metarmor Board Member 000 0000
Kathleen Campbell Metarmor Board Member 000 0000